SCHEMBL19082361

SCHEMBL19082361

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5ccc6c(c5)sc5ccc7sc8c9ccccc9ccc8c7c56)c5ccccc45)c4ccccc34)cccc2c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 5/20 0.39
CYP1B1 Q16678 5/20 0.39
CYP1A2 P05177 3/20 0.38
MCL1 Q07820 2/20 0.35
ACMSD Q8TDX5 1/20 0.35
ALOX5 P09917 1/20 0.35
CA12 O43570 4/20 0.34
CA1 P00915 4/20 0.34
CA2 P00918 4/20 0.34
CA9 Q16790 4/20 0.34
LIMK1 P53667 3/20 0.34
SOS1 Q07889 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
PRKDC P78527 1/20 0.31
EDNRB P24530 1/20 0.31
EDNRA P25101 1/20 0.31
NQO1 P15559 1/20 0.31
NQO2 P16083 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082354 0.93 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2MCL1ACMSD
SCHEMBL19082325 0.92 CYP1A1 (0.40) CYP1A1CYP1B1CYP1A2MCL1LIMK1
SCHEMBL19082238 0.92 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2MCL1ALOX5
SCHEMBL19077425 0.92 ALOX5 (0.40) CYP1A1CYP1B1CYP1A2MCL1ACMSD
SCHEMBL17944649 0.91 MCL1 (0.37) MCL1ACMSDALOX5CA12CA1
SCHEMBL17944378 0.91 MCL1 (0.37) CYP1A1CYP1B1CYP1A2MCL1ACMSD
SCHEMBL19082359 0.91 ALOX5 (0.39) CYP1A1CYP1B1CYP1A2MCL1ACMSD
SCHEMBL19082378 0.91 CYP1A1 (0.37) CYP1A1CYP1B1CYP1A2MCL1ALOX5
SCHEMBL19082267 0.91 CYP1A1 (0.40) CYP1A1CYP1B1CYP1A2MCL1ALOX5
SCHEMBL24341126 0.90 MCL1 (0.35) MCL1ACMSDALOX5CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.